STAMBP

Chr 2AR

STAM binding protein

Also known as: AMSH, MICCAP

Cytokine-mediated signal transduction in the JAK-STAT cascade requires the involvement of adaptor molecules. One such signal-transducing adaptor molecule contains an SH3 domain that is required for induction of MYC and cell growth. The protein encoded by this gene binds to the SH3 domain of the signal-transducing adaptor molecule, and plays a critical role in cytokine-mediated signaling for MYC induction and cell cycle progression. Multiple alternatively spliced transcript variants encoding the same protein isoform have been found for this gene. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.761 OMIM phenotype
Clinical SummarySTAMBP
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
29 unique Pathogenic / Likely Pathogenic· 104 VUS of 253 total submissions
📖
GeneReview available — STAMBP
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.76LOEUF
pLI 0.000
Z-score 2.43
OE 0.46 (0.290.76)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.89Z-score
OE missense 0.84 (0.750.94)
202 obs / 240.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.46 (0.290.76)
00.351.4
Missense OE?0.84 (0.750.94)
00.61.4
Synonymous OE?1.00
01.21.6
LoF obs/exp: 11 / 23.8Missense obs/exp: 202 / 240.7Syn Z: -0.03
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveSTAMBP-related microcephaly-capillary malformation syndromeLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.6745th %ile
GOF
0.5758th %ile
LOF
0.2968th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

253 submitted variants in ClinVar

Classification Summary

Pathogenic13
Likely Pathogenic16
VUS104
Likely Benign70
Benign24
Conflicting7
13
Pathogenic
16
Likely Pathogenic
104
VUS
70
Likely Benign
24
Benign
7
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
8
3
2
0
13
Likely Pathogenic
9
4
3
0
16
VUS
0
97
4
3
104
Likely Benign
0
3
33
34
70
Benign
0
0
21
3
24
Conflicting
7
Total171076340234

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

10 pathogenic / likely-pathogenic (of 14) ClinVar copy-number / structural variants overlap STAMBP — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

STAMBP · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →